Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan L Hudson

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Brain Research|May 5, 2009
Identification of an imidazoline binding protein: creatine kinase and an imidazoline-2 binding siteAtsuko Kimura, Robin J Tyacke, James J Robinson, et al.
Bioorganic & Medicinal Chemistry|December 7, 2010
3-[(Imidazolidin-2-yl)imino]indazole ligands with selectivity for the α(2)-adrenoceptor compared to the imidazoline I(1) receptorFranciszek Sączewski, Anita Kornicka, Alan L Hudson, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 14, 2014
Modulation of resistance artery tone by the trace amine β-phenylethylamine: dual indirect sympathomimetic and α1-adrenoceptor blocking actionsDeepak Narang, Paul M Kerr, Stephanie E Lunn, et al.
Chemical Biology & Drug Design|August 28, 2016
1-[(Imidazolidin-2-yl)imino]-1H-indoles as new hypotensive agents: synthesis and in vitro and in vivo biological studiesAnita Kornicka, Aleksandra Wasilewska, Jarosław Sączewski, et al.
Bioorganic & Medicinal Chemistry|February 29, 2012
Favourable involvement of α2A-adrenoreceptor antagonism in the I₂-imidazoline binding sites-mediated morphine analgesia enhancementValerio Mammoli, Alessandro Bonifazi, Fabio Del Bello, et al.
Synapse (New York, N.Y.)|February 1, 2012
Evaluation and initial in vitro and ex vivo characterization of the potential positron emission tomography ligand, BU99008 (2-(4,5-dihydro-1H-imidazol-2-yl)-1- methyl-1H-indole), for the imidazoline₂ binding siteRobin J Tyacke, Amy Fisher, Emma S J Robinson, et al.
Science (New York, N.Y.)|November 8, 2008
Bioactive contaminants leach from disposable laboratory plasticwareG Reid McDonald, Alan L Hudson, Susan M J Dunn, et al.
Psychopharmacology|March 26, 2003
Behavioral, neuroendocrine and neurochemical effects of the imidazoline I2 receptor selective ligand BU224 in naive rats and rats exposed to the stress of the forced swim testDavid P Finn, Octavi Martí, Michael S Harbuz, et al.
Biochemistry|December 22, 2004
Harmane and harmalan are bioactive components of classical clonidine-displacing substanceChristine A Parker, Neil J Anderson, Emma S J Robinson, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Brain Research|May 5, 2009
Identification of an imidazoline binding protein: creatine kinase and an imidazoline-2 binding siteAtsuko Kimura, Robin J Tyacke, James J Robinson, et al.
Bioorganic & Medicinal Chemistry|December 7, 2010
3-[(Imidazolidin-2-yl)imino]indazole ligands with selectivity for the α(2)-adrenoceptor compared to the imidazoline I(1) receptorFranciszek Sączewski, Anita Kornicka, Alan L Hudson, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 14, 2014
Modulation of resistance artery tone by the trace amine β-phenylethylamine: dual indirect sympathomimetic and α1-adrenoceptor blocking actionsDeepak Narang, Paul M Kerr, Stephanie E Lunn, et al.
Chemical Biology & Drug Design|August 28, 2016
1-[(Imidazolidin-2-yl)imino]-1H-indoles as new hypotensive agents: synthesis and in vitro and in vivo biological studiesAnita Kornicka, Aleksandra Wasilewska, Jarosław Sączewski, et al.
Bioorganic & Medicinal Chemistry|February 29, 2012
Favourable involvement of α2A-adrenoreceptor antagonism in the I₂-imidazoline binding sites-mediated morphine analgesia enhancementValerio Mammoli, Alessandro Bonifazi, Fabio Del Bello, et al.
Synapse (New York, N.Y.)|February 1, 2012
Evaluation and initial in vitro and ex vivo characterization of the potential positron emission tomography ligand, BU99008 (2-(4,5-dihydro-1H-imidazol-2-yl)-1- methyl-1H-indole), for the imidazoline₂ binding siteRobin J Tyacke, Amy Fisher, Emma S J Robinson, et al.
Science (New York, N.Y.)|November 8, 2008
Bioactive contaminants leach from disposable laboratory plasticwareG Reid McDonald, Alan L Hudson, Susan M J Dunn, et al.
Psychopharmacology|March 26, 2003
Behavioral, neuroendocrine and neurochemical effects of the imidazoline I2 receptor selective ligand BU224 in naive rats and rats exposed to the stress of the forced swim testDavid P Finn, Octavi Martí, Michael S Harbuz, et al.
Biochemistry|December 22, 2004
Harmane and harmalan are bioactive components of classical clonidine-displacing substanceChristine A Parker, Neil J Anderson, Emma S J Robinson, et al.
Pageof 4